Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Centre d'Immunologie Pierre Fabre

Division of Pierre Fabre Group

Latest From Alcon Laboratories Inc.

Novartis Hopes Encore Can Lead To Eye-Watering Presbyopia Success

Novartis is buying a privately-held US company started by an ex-Alcon executive which is developing an eye drop aimed at curing presbyopia, a condition affecting some 80% of people over the age of 45.

Commercial Companies

Gender Discrimination Suits: Cases Against Pharma Continue Even As Payouts Slow

Novartis will pay $8m to settle second case; last year Daiichi Sankyo settled gender discrimination class action for the same amount and action against Bayer was dismissed following confidential resolution. Cases are ongoing against Merck and Forest.

BioPharmaceutical United States

All Eyes On Ophthalmic Devices Market

In the ophthalmic device sector, intraocular lens surgery is expanding way beyond the cataract market with paradigm shifting technology. The vast presbyopia market now has an FDA-approved "corneal inlay" option, micro invasive glaucoma surgery has created an entirely new device segment, and corneal cross-linking has the potential to transcend its role as an effective treatment for a corneal disease to possibly being the next big thing in the non-surgical treatment of refractive errors.

Medical Device North America

Ethicon Looks To Jumpstart Robotics Program With Google Partnership

The Johnson & Johnson division plans to work with the technology giant to create a robot-assisted minimally invasive surgery platform.

Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Pierre Fabre Group
  • Senior Management
  • Contact Info
  • Centre d'Immunologie Pierre Fabre
    Phone: (33)
    5, avenue Napoleon III-BP 497
    St. Julien en Genevois Cedex, 74164